TSVT — 2Seventy Bio Cashflow Statement
0.000.00%
Last trade - 00:00- $260.65m
- $85.89m
- $37.86m
- 34
- 23
- 50
- 28
Annual cashflow statement for 2Seventy Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -120 | -292 | -254 | -218 | -57.2 |
| Depreciation | |||||
| Non-Cash Items | 54.6 | 55.5 | 41.4 | 37.8 | -37.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -15.5 | 13.5 | -26.9 | 2.6 | 3 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -67.8 | -207 | -228 | -167 | -85 |
| Capital Expenditures | -22.3 | -19.6 | -30.8 | -13.9 | -0.707 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 1.99 | 34.6 | 57.7 | 81.5 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -22.3 | -17.6 | 3.75 | 43.9 | 80.8 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 90.1 | 355 | 166 | 127 | 0.417 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 130 | -58.2 | 4.39 | -3.82 |